EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024

Code: GDHCER101-15 | Published: Nov-2015 | Pages: 82 | GlobalData
Price :
$3,995.00
USD

* Required Fields

$3,995.00

Details

GlobalData epidemiologists forecast an increase in the total prevalent cases of hand OA in the 7MM from 151,439,533150,635,612 total prevalent cases in 2014 to 176,143,154175,213,683 total prevalent cases in 2024 at an AGR of 1.63% during the forecast period.

GlobalData epidemiologists forecast that the total prevalent cases of knee OA in the 7MM are expected to increase from 110,840,501 total prevalent cases in 2014 to 127,929,359 total prevalent cases in 2024 at an AGR of 1.54% during the forecast period.

GlobalData epidemiologists forecast that the total prevalent cases of hip OA in the 7MM are expected to increase from 61,150,916 total prevalent cases in 2014 to 69,699,696 total prevalent cases in 2024 at an AGR of 1.4% during the forecast period.

The diagnosed prevalent cases of hand OA in the 7MM are expected to increase from 61,045,59060,125,229 diagnosed prevalent cases in 2014 to 70,996,37570,072,690 diagnosed prevalent cases in 2024 at an AGR of 1.635% during the forecast period.

The diagnosed prevalent cases of knee OA in the 7MM are expected to increase from 37,845,305 diagnosed prevalent cases in 2014 to 43,877,213 diagnosed prevalent cases in 2024 at an AGR of 1.59% during the forecast period.

The diagnosed prevalent cases of hip OA in the 7MM are expected to increase from 15,116,094 diagnosed prevalent cases in 2014 to 17,276,030 diagnosed prevalent cases in 2024 at an AGR of 1.43% during the forecast period.

Scope

- The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for hand OA, knee OA, and hip OA in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). The report also includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of hand OA, knee OA, and hip OA segmented by age and sex in these markets.
- The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global OA market.
- Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
GlobalData

Our Clients